Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Avista
AVA
$3.23B
| $946K | ﹤0.01% |
25,531
-3,668
| -13% | -$153K |
|
2202
ePlus
PLUS
$2.39B
| $946K | ﹤0.01% |
22,757
-17,690
| -44% | -$866K |
|
2203
CALL
Philip Morris
PM
$294B
| $946K | ﹤0.01% |
11,400
+2,400
| +27% | +$229K |
|
2204
iShares MSCI Taiwan ETF
EWT
$10.6B
| $945K | ﹤0.01% |
21,926
-46,318
| -68% | -$2.29M |
|
2205
Sally Beauty Holdings
SBH
$1.52B
| $945K | ﹤0.01% |
74,998
-377
| -0.5% | -$5.23K |
|
|
VLD
2206
DELISTED
Velo3D, Inc.
VLD
| $945K | ﹤0.01% |
6,856
+1,337
| +24% | +$174K |
|
|
VIVO
2207
DELISTED
Meridian Bioscience Inc
VIVO
| $945K | ﹤0.01% |
29,974
+16,434
| +121% | +$532K |
|
2208
AAR Corp
AIR
$6.01B
| $944K | ﹤0.01% |
26,383
+2,899
| +12% | +$123K |
|
2209
Alamo Group
ALG
$2.04B
| $944K | ﹤0.01% |
7,722
-554
| -7% | -$70.4K |
|
2210
Sylvamo
SLVM
$1.52B
| $943K | ﹤0.01% |
27,801
+14,940
| +116% | +$567K |
|
|
LMACU
2211
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
| $938K | ﹤0.01% |
+94,272
| New | +$935K |
|
|
SCLE
2212
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
| $937K | ﹤0.01% |
95,050
| – | – |
|
2213
Core & Main
CNM
$8.61B
| $933K | ﹤0.01% |
41,021
+34,779
| +557% | +$813K |
|
2214
LivePerson
LPSN
$27.6M
| $931K | ﹤0.01% |
6,594
-2,014
| -23% | -$386K |
|
2215
LiveRamp
RAMP
$2.3B
| $931K | ﹤0.01% |
51,276
+13,822
| +37% | +$319K |
|
|
WIRE
2216
DELISTED
Encore Wire Corp
WIRE
| $930K | ﹤0.01% |
8,051
-2,400
| -23% | -$292K |
|
|
MMX
2217
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $930K | ﹤0.01% |
277,624
+277,324
| +92,441% | +$1.05M |
|
2218
Provident Financial Services
PFS
$3.26B
| $929K | ﹤0.01% |
47,643
+23,910
| +101% | +$558K |
|
2219
Remitly
RELY
$5.43B
| $929K | ﹤0.01% |
83,446
+69,694
| +507% | +$727K |
|
|
VIGL
2220
DELISTED
Vigil Neuroscience
VIGL
| $929K | ﹤0.01% |
102,163
+482
| +0.5% | +$3.54K |
|
|
YMAB
2221
DELISTED
Y-mAbs Therapeutics
YMAB
| $929K | ﹤0.01% |
64,445
+61,634
| +2,193% | +$1.02M |
|
2222
MP Materials
MP
$8.51B
| $928K | ﹤0.01% |
34,049
-252,006
| -88% | -$8.24M |
|
2223
M/I Homes
MHO
$3.73B
| $927K | ﹤0.01% |
25,580
-8,196
| -24% | -$354K |
|
2224
iShares MSCI Australia ETF
EWA
$1.44B
| $925K | ﹤0.01% |
47,124
-67,766
| -59% | -$1.47M |
|
2225
Pacira BioSciences
PCRX
$1.02B
| $924K | ﹤0.01% |
17,385
-5,520
| -24% | -$307K |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $66.4B in Q3 2022, closing 532 positions and reducing 1,954 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $99.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Pacer iPath Gold ETNs worth $27.1M.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 532 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.